Literature DB >> 19643049

Europe's initial experience with pandemic (H1N1) 2009 - mitigation and delaying policies and practices.

A Nicoll1, D Coulombier.   

Abstract

Europe has experienced more than two months of the first transmissions and outbreak of the 2009 pandemic of A(H1N1)v. This article summarises some of the experience to date and looks towards the expected autumn increases of influenza activity that will affect every country. To date the distribution of transmission has been highly heterogenous between and within countries, with one country the United Kingdom (UK) experiencing the most cases and the highest transmission rates. Most infections are mild but there are steadily increasing numbers of people needing hospital care and more deaths are being reported. An initial difference in practice between Europe and North America was over case-finding and treatment with some authorities in Europe using active case-finding, contact tracing and treatment/prophylaxis with antivirals to try and delay transmission. This article details the history of this practice in the past two months and explains how and why countries are moving to mitigation, especially treating with antivirals those at higher risk of experiencing severe disease.

Entities:  

Mesh:

Year:  2009        PMID: 19643049     DOI: 10.2807/ese.14.29.19279-en

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  21 in total

1.  Selecting nonpharmaceutical strategies to minimize influenza spread: the 2009 influenza A (H1N1) pandemic and beyond.

Authors:  Lisa C Barrios; Lisa M Koonin; Katrin S Kohl; Martin Cetron
Journal:  Public Health Rep       Date:  2012 Nov-Dec       Impact factor: 2.792

2.  First evidence of a pro-inflammatory response to severe infection with influenza virus H1N1.

Authors:  Isabel Fernández de Castro; María Guzmán-Fulgencio; Mónica García-Alvarez; Salvador Resino
Journal:  Crit Care       Date:  2010-02-11       Impact factor: 9.097

Review 3.  Reflections on pandemic (H1N1) 2009 and the international response.

Authors:  Gabriel M Leung; Angus Nicoll
Journal:  PLoS Med       Date:  2010-10-05       Impact factor: 11.069

4.  Developing guidelines for school closure interventions to be used during a future influenza pandemic.

Authors:  Nilimesh Halder; Joel K Kelso; George J Milne
Journal:  BMC Infect Dis       Date:  2010-07-27       Impact factor: 3.090

5.  Interest of a simple on-line screening registry for measuring ICU burden related to an influenza pandemic.

Authors:  Jean-Christophe Marie Richard; Tài Pham; Christian Brun-Buisson; Jean Reignier; Alain Mercat; Gaëtan Beduneau; Bernard Régnier; Bruno Mourvillier; Christophe Guitton; Matthias Castanier; Alain Combes; Yves Le Tulzo; Laurent Brochard
Journal:  Crit Care       Date:  2012-07-09       Impact factor: 9.097

6.  The impact of case diagnosis coverage and diagnosis delays on the effectiveness of antiviral strategies in mitigating pandemic influenza A/H1N1 2009.

Authors:  Joel K Kelso; Nilimesh Halder; George J Milne
Journal:  PLoS One       Date:  2010-11-03       Impact factor: 3.240

7.  The novel influenza A (H1N1) virus pandemic: An update.

Authors:  N Petrosillo; S Di Bella; C M Drapeau; E Grilli
Journal:  Ann Thorac Med       Date:  2009-10       Impact factor: 2.219

8.  Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza.

Authors:  Jesus F Bermejo-Martin; Raul Ortiz de Lejarazu; Tomas Pumarola; Jordi Rello; Raquel Almansa; Paula Ramírez; Ignacio Martin-Loeches; David Varillas; Maria C Gallegos; Carlos Serón; Dariela Micheloud; Jose Manuel Gomez; Alberto Tenorio-Abreu; María J Ramos; M Lourdes Molina; Samantha Huidobro; Elia Sanchez; Mónica Gordón; Victoria Fernández; Alberto Del Castillo; Ma Angeles Marcos; Beatriz Villanueva; Carlos Javier López; Mario Rodríguez-Domínguez; Juan-Carlos Galan; Rafael Cantón; Aurora Lietor; Silvia Rojo; Jose M Eiros; Carmen Hinojosa; Isabel Gonzalez; Nuria Torner; David Banner; Alberto Leon; Pablo Cuesta; Thomas Rowe; David J Kelvin
Journal:  Crit Care       Date:  2009-12-11       Impact factor: 9.097

9.  Economic analysis of pandemic influenza mitigation strategies for five pandemic severity categories.

Authors:  Joel K Kelso; Nilimesh Halder; Maarten J Postma; George J Milne
Journal:  BMC Public Health       Date:  2013-03-08       Impact factor: 3.295

10.  Epidemiological consequences of household-based antiviral prophylaxis for pandemic influenza.

Authors:  Andrew J Black; Thomas House; M J Keeling; J V Ross
Journal:  J R Soc Interface       Date:  2013-02-06       Impact factor: 4.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.